-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Raised to $17 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on CytomX Therapeutics (CTMX)
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Tops Q2 EPS by 6c, Misses on Revenue
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on CytomX Therapeutics (CTMX)
-
-
-
-
-
456,578 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

